Fig. 1From: Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022Effect of an increase in length of ME (left) and partnership solution (right) on the rNPV of a hypothetical ultra-rare OMP [3]. ME = market exclusivity, rNPV = risk-adjusted net present valueBack to article page